What redesigning medical school might look like

What redesigning medical school might look like

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Our executive editor was dismayed yesterday when he learned that not everyone at STAT was familiar with this bop about percolators. Do you know it? I hope that vibe can carry you through the morning. Expected, but still shameful: U.S. lost measles elimination status International health officials declared yesterday that measles is no longer considered eliminated in the U.S. As STAT reporter Drew Joseph puts it, the finding was widely expected, but “marks an embarrassing and avoidable backslide in the country’s basic public health standing.” It’s a largely symbolic gesture to recognize the transmission that’s already occurred. But it could have political ramifications, with resurgent Democrats already attacking the Trump administration — especially health secretary Robert F. Kennedy Jr. — for not responding forcefully to recent outbreaks and for mixed messaging around the benefits of vaccination. Read more from Drew on what could happen next. White House pulls Heidi Overton nomination The Trump administration is pulling its nominee to lead the Food and Drug Administration, Heidi Overton, according to a White House official and a source close to Overton. STAT’s Margaret Manto and Daniel Payne confirmed the news at dinnertime yesterday after it was first reported by Axios. The decision follows concerns that Overton, a preventive care doctor who previously served in the Trump White House, lacked sufficient support from Republicans on the Senate’s health panel, which had been expected to vote on her nomination today. Read more. Should we reimagine medical school? This fall, STAT’s First Opinion editor Torie Bosch is publishing a fascinating series of essays on what it might look like to redesign medical school. In the second installment, a student proposes what she calls a centralized “core-to-clinic” model. In this model, students could enroll in a centralized, digital curriculum after meeting basic criteria, like a minimum MCAT score. (This would only include pre-clerkship studies, before students start getting more hands-on training at clinical sites.) “I realize that proposing a major restructuring of medical school is likely to provoke skepticism.” writes M.D./Ph.D. student Alex Serafini. Still, “I am asking whether every part of that infrastructure needs to be bundled into the same four-year institution.” Read more. And if you missed the first essay in this series — arguing that medical school should start after students take the infamous Step 1 exam — go check it out. 9 That’s the number of states that have met the Healthy People 2030 target rate for preterm birth, according to the March of Dimes annual report card published yesterday. In 2025, the national average preterm birth rate was 10.4% for the fourth year in a row, which is 1% higher than the goal rate of 9.4%. (Healthy People 2030 is a set of goals for the decade, set by the government, to improve the nation’s health.) Sixteen states met the 2030 target for infant mortality of 5 deaths per 1,000 births. While the infant mortality rate has declined nearly 20% in as many years, the rate among babies born to Black parents is still twice the national average. Will science miss Susan Collins? Sen. Susan Collins, R-Maine, arrives to elect Republican leadership following the sweeping victory by Democrats in the midterm elections, at the Capitol in Washington, Tuesday, Nov. 10, 2026. (AP Photo/J. Scott Applewhite)J. Scott Applewhite/AP Many science advocates celebrated the blue wave that swept the midterms, including the election of scientists and physicians to a record number of seats in Congress. But there’s one unusual ally they may be missing next year. Sen. Susan Collins (R-Maine) has frequently pushed back on the White House’s attempts to slow down science funding, or use it as a political tool. But after losing her seat in the midterms — and with it, her perch atop the Senate appropriations committee — it’s unclear who in her party might take up the mantle. Read more from STAT’s Anil Oza and John Wilkerson on which names are being floated by hopeful science advocates, along with which battles those representatives will be inheriting. Chronic disease advocates disappointed by 2027 funding Senate appropriators this week released a fiscal year 2027 funding bill for the Department of Health and Human Services, and some patient-advocates are less than pleased. While the bill devotes an extra $500 million (above 2026 levels) to research at the National Institutes of Health, it gives zero additional dedicated funding to the study of myalgic encephalomyelitis/chronic fatigue syndrome. The exclusion of ME/CFS — a little-understood, debilitating chronic health condition with no approved therapies and severe impacts on daily life — comes a year after senators urged the NIH to implement its ME/CFS Research Roadmap. Advocates asked Congress to support the roadmap with an extra $50 million. NIH currently spends $13 million annually, or less than 0.03% of its overall budget, on ME/CFS research. “NIH shouldn’t wait,” Elizabeth Ansell, executive director of #NotJustFatigue, told STAT in a text message. Sub-agencies have money they can put toward ME/CFS research. “Start putting those resources to work instead of waiting for another funding cycle.” — Isabella Cueto What we’re reading An almost entirely unregulated corner of the health care workforce, The Atlantic Does this man have a right to the data from his own brain? New York Times Opinion: RFK Jr. has got to go, STAT The $200,000 woman: How donors’ tissue is turned into boob jobs and butt lifts, Business Insider Boston is a medical powerhouse. Why is it so hard to get primary care? Boston Globe

Original Source

Read the full article at Statnews →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.